Cytotoxic T lymphocyte (CTL)-mediated cytolysis is induced via the Interaction of the specific T-cell antigen receptor and the peptidic viral antigen assodated with the major histocompatibility complex class I antigen. Here we demonstrate in vitro that lymphocytic choriomeningitis virus (LCMV) can escape the cytotoxic activity of LCMV-specific cloned CTLs by single amino acid changes within the recognized T-cell epitope defined by residues 275-289 of the LCMV glycoprotein [LCMV-GP4275-289)]. LCMV-infected fibroblasts at a multiplicity of infection of 10-3 exposed to virus specific CTL at an effector-to-target cell ratio of 4:1 4 hr after infection was optimal for virus mutant selection. The selections were carried out with three LCMV-GP-(275-289)-speciflc CTL clones expressing T-cell antigen receptors containing the identical variable gene segments VA and V1310 but different junctional regions; selection was also possible with LCMV-GP-(275-289)-specific cytotoxic polyclonal T cells. The most common escape mutation was an amino acid change of asparagine (AAT) to aspartic acid (GAT) at position 280; an additional mutation was glycine (GGT) to aspartic acid (GAT) at position 282. The results presented show that relevant point mutations within the T-cell epitope of LCMV-GP-(275-289) occur frequently and that they are selectable in vitro by CTLs.
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Viruses may escape immune surveillance by altering antigenic determinants recognized by neutralizing antibodies. This has been documented by the classical studies on influenza virus epidemiology; selected virus determinants may shift and drift antigenically to escape neutralizing antibodymediated immunity. Also, neutralizing monoclonal antibodies (mAbs) against rabies, influenza viruses, and other viruses have been shown to rapidly select escape mutants in vitro (1) (2) (3) (4) (5) .
Recently evidence that viruses may also escape immune surveillance by mutating a crucial T-cell epitope has been found in vivo in T-cell antigen receptor (TCR) transgenic mice acutely infected with lymphocytic choriomeningitis virus (LCMV) (6) . Many unpublished attempts have been made over the past several years to select cytotoxic T-cell escape mutant viruses in vitro without success by using cytotoxic T-cell clones. Several observations suggest that such an escape from cytotoxic T-cell surveillance by the loss of the relevant T-cell epitope might exist (7) (8) (9) . The rapid isolation of mutant viruses using T cells might prove useful to study immunodominance and flexibility of defined T-cell epitopes or to analyze TCR repertoires for particular epitopes. Therefore a method for the isolation of mutant viruses by using cytotoxic T cells in vitro would be highly desirable.
The present study shows that selection of virus variants in vitro by cytotoxic T lymphocytes (CTLs) is readily feasible.
LCMV epitope-specific CTLs, either cloned or polyclonal, were used successfully in a mixed culture with LCMVinfected target cells to select mutant virus; the efficiency of selection was comparable to that reported with neutralizing antibodies. Isolated mutant viruses show point mutations in the relevant T-cell epitopes and were no longer recognized by the CTLs present during the selection. tTo whom reprint requests should be addressed.
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overlaid with 3 ml of Eagle's minimal essential medium containing 5% fetal calf serum. CTLs (2.4 x 106) were added 1 or 4 h later unless otherwise indicated (see Table 1 ). Supernatants containing virus were collected after 48 h, titrated on L929 cells as described (15) , and tested in a standard cytotoxicity assay. Virus isolates were cloned twice by plaque purification as described (16) . On occasions where the cytotoxicity of the selector CTLs toward targets infected with the selected virus was reduced by only 50%, a second selection cycle was carried out. Titrated virus supernatant after the first selection cycle was used, and the selection with cloned CTLs or LCMV-GP-(275-289)-specific splenocytes was repeated.
Cytotoxicity Assay. Target cells were infected with virus (moi = 0.1) for 40 h. The lytic activity of the different effector cells was determined in a standard 51Cr-release assay for 4-5 h as described in detail elsewhere (12) .
Sequencing of the Relevant CTL Epitopes of the LCMV Isolates. LCMV was purified from infected L929 cells (16) , and viral RNA was extracted as described elsewhere (17) . Viral RNA (1 ug) was used as a template for cDNA synthesis with reverse transcriptase (Moloney murine leukemia virus; Pharmacia) and a specific primer (5'-TCGTAGCATGTCA-CAGAATTCTTC-3'). One-fiftieth of the cDNA mixture was amplified by PCR using Taq polymerase (Boehringer Mannheim) with a second specific primer (5'-GAATTCTATC-CAGTAAAAGGA-3') (18) . PCR was run for 42 cycles using a thermal cycler (Perkin-Elmer/Cetus). Denaturation was for 1 min at 940C, annealing was for 1.5 min at 420C, and extension was for 3 min at 72TC. The amplified 980-base-pair fragment was digested with EcoRI, and the resulting 473-and 487-base-pair fragments were cloned into pUC18. Colonies were sequenced in both directions by the dideoxynucleotide chain-termination method using Sequenase (United States Biochemical). The DNA comparison and homology search was done with the PC program DNA* (DNA*, Madison, WI). The nucleotide sequence for the glycoprotein is given as the viral-sense DNA (18) .
mAbs. Hybridoma supernatants of 141-51.2 (anti-H-2Db) (19) and B8-24-3 (anti-H-2Kb) (20) were used at a 1:4 dilution. 30 cycles using a thermal cycler. Denaturation was performed for 1 min at 95°C, annealing was performed for 1 min at 48°C, and extension was performed for 3 min at 72°C. The amplified a-chain fragment and the (-chain fragments were digested with Pst I plus BamHI and Pst I plus Sac I, respectively, and the resulting fragments were cloned into pUC18. Positive colonies were sequenced by the dideoxynucleotide method.
RESULTS Parameters Influeg the in Vitro Selection of LCMV Variants by CTLs. Cloned LCMV-GP-(275-289)-specific H-2Db1 restricted CTLs (11, 12) were used with LCMV-infected B6-SV40 fibroblasts in a mixed culture system to select virus variants. These cloned CTLs are highly cytotoxic at an effector-to-target cell ratio of >3:1 as shown for a representative clone, 50.1, in Fig. 1 . To select virus variants, CTL clone 50.1 was added at an effector-to-target cell ratio of 4:1 to B6-SV40 fibroblasts infected at an moi of 1 and 10-3, respectively, to ensure a high selective pressure. The results summarized in Fig. 1 show that variant virus that was no longer recognized by CTL clone 50.1 seemed to predominate in the supernatant of these cultures. Clone 3D5 with a specificity for another T-cell epitope on the LCMV glycoprotein (amino acid residues 32-42) (14) was still able to efficiently lyse virus variantinfected target cells ( Figs. 1 and 2) .
It is possible that mutant virus could be present at a low frequency in the initial inoculum despite the fact it had been triple plaque purified before the selection procedure (16) Proc. Natl. Acad. Sci. USA 88 (1991) infection (Fig. 2) . When CTLs were added 16 h after the infection, leaving time for a complete first replication cycle of the virus (12-14 h), selection was less complete when cells were infected at a moi of lo-3 and was ineffective at an moi of 1. The degree of cell-mediated lysis of target cells infected with identical moi of virus from supernatants after selection indirectly represents the efficiency of virus variant selection (solid bars in Fig. 2) .
The changes in antigenicity of the variant virus were T-cell epitope specific. Target cells infected with mutant virus were still recognized by 3D5, a LCMV-GP-(32-42)-specific CTL clone as well as by polyclonal (and polyspecific) primary anti-LCMV immune spleen cells. Interestingly, the efficient selection seen at an moi of 10-3 was not found at very low moi values, when fibroblasts were infected at an moi of 10-5 (data not shown).
The importance of a sufficiently strong selective pressure is documented in Fig. 3 , where the number of CTLs added to the infected fibroblasts was titrated. Selection ofvariant virus did not occur at an effector-to-target cell ratio of <0.7:1. This corresponded to a cytolytic activity of the CTLs below 50%o in a standard 51Cr-release assay (Fig. 1) . It has to be noted, on the other hand, that selection was not prevented by adding a 20-fold excess of CTLs. From these results, it was concluded that under the experimental conditions used addition of CTLs at a 4:1 excess over infected fibroblasts, 4 h after infection with LCMV at an moi of 10-3, appeared to be optimal for virus variant selection. Therefore the following experiments were performed using these standard parameters.
Selection of LCMV Variants in Vitro by Other CTLs and on
Other Target Cells. When the LCMV-GP-(275-289)-specific CTL clones B23.35 or B12 were used to select variants, the results were identical to the selection with 50.1 (Fig. 4) . However, two cycles of selection were necessary for the complete loss of the parental LCMV-WE phenotype in virus from the supernatant of cultures when selecting with CTL clone B23.35 (data not shown). Again the other CTL epitope monitored was not changed (Fig. 4) . Not only were the selected variants no longer recognized by the CTLs present during the selection (data not shown), but in addition they were not recognized by other CTL clones with the same fine specificity (Fig. 4) . Although these CTL clones express all Va4 and V,10 TCR variable regions (21), they were heterogeneous in the primary sequence of their TCR junctional (J) regions as determined by sequencing (Fig. 5) . Whereas clone (Fig. 4) .
Attempts to select virus variants with an altered LCMV-GP-(32-42) T-cell epitope have failed so far with two cytotoxic T-cell clones or lines available.
Thus, virus variant selection in vitro is feasible. The efficiency ofthe selection might be higher or lower depending upon the CTL clone used.
To formally prove that selection depended upon cognate interaction of the CTL and its TCR with the infected target cell and the relevant major histocompatibility complexantigen complex, selection was carried out as follows. Target cells of H-2d haplotype (D2) were infected with LCMV-WE stock virus at an moi of 10-3. No variant virus could be detected in supernatants when the LCMV-GP-(275-289)-specific H-2Db-restricted CTL clone 50.1 was added to these cells. In contrast, when MC57G cells (H-2b) were infected, variants could be selected with the same efficiency as with the routinely used B6-SV40 fibroblasts. In a second set of experiments, mAbs specific for H-2Db or H-2Kb were added to the cultures. Virus from the supernatant of infected fibroblasts selected with CTL clone 50.1 in the presence ofan H-2Db-specific mAb (141-51.2) was still recognized by 50.1, whereas virus selected in the presence of an H-2Kb-specific mAb (B8-24-3) was not (data not shown).
Variants Show a Point Mutation Leading to an Amino Acid Substitution in the Relevant CTL Epitope. To determine the amino acid sequence of the relevant CTL epitopes from the phenotypically mutant viruses, variants were cloned by double plaque purifications and tested in a 51Cr-release assay. Finally viral RNA was prepared, and the cDNA corresponding to the relevant CTL epitope region was sequenced. The results are summarized in Table 1 . Nine independently selected variant virus isolates were subcloned and retested for their phenotypes. At least two subcloned isolates of each original plaque-purified variant were sequenced in both directions. All of the LCMV-GP-(275-289) variants examined except one were of identical genotype despite the fact that they had been selected in separate experiments and by different CTL populations (Table 1) .
Immunology: Aebischer et al. GGT  CTC ATG TCT AAT TAC AAC GTM CTT TAC TTC GGA TCT GGC TCC AAA CTC ACT GTA GAG Co3 A point mutation from adenosine to guanosine leading to an amino acid substitution at position 280 of the LCMV glycoprotein, asparagine replaced by aspartic acid [variant LCMV-WE(280D)], was the common virus variant genotype. This was detected in virus isolates after selection with CTL clones 50.1 and B23.35 or LCMV-GP-275-289)-specific splenocytes. These variants exhibited no mutation in the LCMV-GP-(32-42) epitope (Fig. 4 and data not shown) .
This uniform pattern of sequences in the LCMV-GP-(275-289) variants could be explained by selection of a preexisting mutant present at a very low frequency in the stock virus. To control for this possibility, selection was repeated with a fireshly triple-plaque-purified isolate, which also served as a control virus exhibiting the correct wild-type LCMV-GP-(275-289) sequence (see above) EL 1.1 (Table 1) . When B6-SV40 fibroblasts were infected with LCMV-WE at an moi of 10-3 and B23.35 was added in a first selection cycle and 50.1 CTL was added in a second selection cycle at the standard ratio of 4:1, mutant virus EL-B23(3.2) was detected in the supernatant (Table 1) . In contrast to the virus selected out of the original LCMV-WE stock, a variant plaquepurified isolate showed a point mutation leading to a substitution of aspartic acid for glycine at position 282 [variant LCMV-WE(282D); Table 1 ].
Control virus passaged on B6-SV40 fibroblasts and plaque purified was phenotypically and genotypically of parental LCMV-WE type (Fig. 4) (1) (2) (3) (4) (5) . The mechanism by which the virus escaped CTL attack seems to be identical in vitro and in vivo (6) . Point mutations within the epitope recognized by specific CTLs led to amino acid substitution and consequently to a failure of recognition (22) (27) . Variability in this part of the TCR molecule has been shown to counterbalance variation in the epitope sequence (28) (29) (30) (31) (32) . In addition this virus variant could be selected by polyclonal LCMV-GP-(275-289)-specific CTLs. In other words, the LCMV-WE(280D) mutation seemed to drastically affect the antigenicity of the LCMV-GP-(275-289) epitope and possibly also its immunogenicity.
Whether the variants selected in vitro actually arose during the selective process in a directed manner under the driving force of the CTLs or were present in a surprisingly high but undetected frequency among the initial inoculum cannot be answered absolutely. The following considerations may apply. First, a very high excess in the number of CTLs over infectable target cells did not prevent selection. In this situation, virus-infected cells should presumably be eliminated before any virus progeny would emerge. Second, no virus variants could be selected when target cells were infected at a very limiting moi. However, a mutated virus could be selected from a freshly plaque-purified and sequenced control LCMV-WE isolate using an moi of 10-3. It may, however, be safely stated that among the 6 X 102 pfu applied at least 1 mutant virus (i.e., 1 pfu) should have been present; therefore, one might have expected to find such frequent mutants more easily. Replication of 1 virus results in at least 1000 progeny virus. Since one replication cycle may occur in one selection round, true frequencies of relevant mutations cannot be defined in this system.
We therefore should like to argue that the more likely sequence of events is that the mutant virus arose during the first round after infection of the target cells in the selection assay or was contained in the virus stock, unless all experiments can be done with the same virus particle. From a practical point of view, the results indicate that the relevant mutations occur frequently and that they are selectable in vitro by CTLs. As suggested by our experience, this may not always happen in a single round of selection. The described methods should open up experimental analysis of T-cell epitopes and TCR specificities by using specific CTLdirected mutation selection of biologically relevant CTL epitopes in a nonrandom fashion.
